The indispensable roles of TAMs and p53 in ICI efficacy have been established [3, 47, 48], with TP53 diminishing PD-L1 expression in tumor cells and targeting the promoter of DD1α to enhance macrophage-mediated clearance of dead cells [49, 50]. The gene discussed is CD274; the disease is neoplasm.